Processing upwards of $70 billion in pharmacy transactions for 1 in 6 U.S. healthcare consumers, leading PBM Prime Therapeutics has grown rapidly in recent years to not only serve its 19 Blues plan owners but more than 80 other health plans.

With a focus on modernizing technology and data to simplify the healthcare experience, Prime is making no small plans: “We want to be the nation’s pharmacy partner of choice by providing the kind of care we want for our loved ones,” says Matthew Mertel, Prime Therapeutics SVP, COO. Matt joins our CEO Minal Patel, MD, in the latest edition of Abacus Insights Health Planning series to discuss this strategy.

To learn more about Abacus Insights, contact us at info@abacusinsights.com